Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04363164
Title Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

prostate adenocarcinoma

Therapies

Testosterone Enanthate

Testosterone cypionate

Enzalutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.